Peerapol Wangrattanapranee

BACKGROUND: Biological treatment in inflammatory bowel disease (IBD) patients is currently hampered by high non-response rates. To enhance personalized medicine and predict response to biological therapeutics such as vedolizumab, the working mechanism should be elucidated…

The current GI guideline recommendations for early diagnosis and lesion localization of patients with severe LGIB are to perform computerized tomography angiography (CTA) or labelled red blood cell (RBC) scanning and not urgent colonoscopy. However, only active bleeding (e.g…